South Dakota Senate Bill SB122

South Dakota 2023 Regular Session

• Introduced: 1/26/23
• Refer: 1/26/23

Caption

Address the potential abuse of opiate and opioid drugs.

Impact

The legislation impacts existing regulations under chapter 34-20B concerning the prescribing of controlled substances. It proposes limits on the duration and quantity of opioid prescriptions, particularly for emergency patients, minors, and initial visits. For example, prescriptions for adults in an emergency room or clinic cannot exceed four days, while those issued to minors cannot exceed three days, thus fostering safer prescribing practices. If treatment extends beyond 30 days, additional checks are enforced including repeated examinations and a signed narcotics-use document from the patient, ensuring ongoing monitoring for safety and efficacy.

Summary

Senate Bill 122, introduced by Senator Frye-Mueller, seeks to curb the potential abuse of opioid drugs through stricter regulations on prescribing practices. The bill mandates that before practitioners can issue an initial prescription for a Schedule II opiate or opioid drug, they must inform patients about the risks, document the patient's medication history, conduct a physical examination, create a treatment plan, and offer the option of a lesser quantity of the drug. This process is designed to ensure that patients receive comprehensive care and are aware of the dangers associated with opioid medication use.

Contention

Despite the intent to reduce opioid misuse, the bill has sparked discussions among healthcare providers regarding its implications on patient care. Supporters argue that these measures will help mitigate the opioid crisis and protect patients from addiction risks, while opponents highlight concerns about potential barriers to legitimate pain management. They argue that the strict regulations might hinder access to necessary medications for patients with chronic pain, thus impacting their quality of life. Additionally, critics express unease over the burden placed on practitioners in terms of paperwork and compliance requirements, which could deter them from prescribing essential treatments.

Notable_points

The bill allows exemptions for patients receiving specific types of care, such as those in hospitals, cancer treatment, or palliative care, indicating a recognition of the need for comprehensive pain management methods in sensitive circumstances. It also provides clarity on the repercussions of violating the terms of the narcotics-use document, empowering practitioners to sever ties with non-compliant patients. This establishes a framework that prioritizes safety while attempting to balance the need for responsible pain management.